Pharmacokinetics and Pharmacogenetics of Cyclophosphamide in a Neonate and Infant Childhood Cancer Patient Population

Infants and young children represent an important but much understudied childhood cancer patient population. The pharmacokinetics and pharmacogenetics of the widely used anticancer prodrug cyclophosphamide were investigated in children <2 years of age. Concentrations of cyclophosphamide and selec...

Descripción completa

Detalles Bibliográficos
Autores principales: Barnett, Shelby, Errington, Julie, Sludden, Julieann, Jamieson, David, Poinsignon, Vianney, Paci, Angelo, Veal, Gareth J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8002238/
https://www.ncbi.nlm.nih.gov/pubmed/33809608
http://dx.doi.org/10.3390/ph14030272

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8002238/
https://www.ncbi.nlm.nih.gov/pubmed/33809608
http://dx.doi.org/10.3390/ph14030272

Ejemplares similares